Ovarian Cancer Survival Rate: Is It 100%?

Ovarian cancer is a complex disease. While treatment advances offer hope, the reality is more nuanced. The overall 5-year relative survival rate for ovarian cancer in the United States is 51.6%. This number changes a lot based on when the cancer is found.

When found early, the survival rate is much better. It’s about 91-95% at stage I. But, the survival rate falls to 15-20% for stage IV. At Liv Hospital, we focus on the latest treatments to help patients.

Learn the truth about the ovarian cancer survival rate and find out which stages are considered 100% curable with modern medicine today.

Key Takeaways

• The overall 5-year relative survival rate for ovarian cancer is 51.6%.
• Survival rates vary significantly by stage at diagnosis.
• Early detection significantly improves survival rates.
• Liv Hospital provides internationally competitive outcomes and the latest treatments.
• Advances in medical treatments are continually improving patient outcomes.

The Reality of Ovarian Cancer Curability

The idea of a “cure” in ovarian cancer treatment is complex. When people ask if ovarian cancer is 100% curable, they want a simple answer. But the truth is more complicated.

Defining “Cure” in Cancer Treatment

In cancer treatment, a “cure” means the disease is controlled, and there’s no sign of it coming back. For ovarian cancer, the cure rate depends on when it’s found. Early-stage ovarian cancer has a better chance of being cured than later stages.

“The five-year survival rate for ovarian cancer has improved over time, but it remains heavily dependent on the stage at diagnosis.” – American Cancer Society

It’s important to know what affects if a cancer can be cured. These include the cancer’s type and stage, the patient’s health, and how well the treatment works.

Why Ovarian Cancer Isn’t 100% Curable

Ovarian cancer is often found late, making treatment harder and reducing the chance of a full cure. Late detection is a big problem in treating ovarian cancer.

Stage at Diagnosis	5-Year Survival Rate
Stage I	90%
Stage II	70%
Stage III	39%
Stage IV	17%

The table shows how the stage at diagnosis affects survival rates for ovarian cancer. It’s clear that finding cancer early is key to better treatment results.

Understanding Ovarian Cancer

Ovarian cancer is a serious disease that starts in the ovaries. It’s hard to diagnose and treat. This cancer can be divided into different types based on where it starts.

What is Ovarian Cancer?

Ovarian cancer starts in the ovaries, which are part of the female reproductive system. It can happen at any age but is more common in women over 50.

We don’t know all the causes of ovarian cancer. But, we do know some things that might make it more likely to happen.

Types and Classifications

Ovarian cancer is mainly divided into three types based on where it starts:

• Epithelial ovarian cancer: This is the most common type, starting in the outer layer of the ovary.
• Germ cell ovarian cancer: This type starts in the cells that make eggs.
• Stromal ovarian cancer: It starts in the ovary’s connective tissue.

Type of Ovarian Cancer	Cell Origin	Frequency
Epithelial	Outer layer of the ovary	Most common
Germ cell	Cells that produce eggs	Less common
Stromal	Connective tissue of the ovary	Rare

Why It’s Called the “Silent Killer”

Ovarian cancer is called the “silent killer” because its early symptoms are vague. This makes it hard to catch until it’s too late.

Early symptoms include bloating, pelvic pain, and trouble eating. But, these can be mistaken for other, less serious problems.

Knowing about ovarian cancer, its types, and how it works is key to better diagnosis and treatment. We’ll look at survival rates and treatment options next.

Ovarian Cancer Survival Rate: Current Statistics

Recent data on ovarian cancer survival rates give us a clear picture of the disease’s outlook. It’s vital for patients and doctors to know these numbers. They help in making the best treatment and care plans.

Overall 5-Year Survival Rate in the United States

The 5-year survival rate for ovarian cancer in the U.S. is 51.6%. This means women with ovarian cancer have a 51.6% chance of living 5 years after diagnosis. This rate is compared to women of the same age without the disease. Remember, survival rates can change a lot based on when the cancer is found.

Stage-Specific Survival Rates

Survival rates for ovarian cancer depend a lot on the cancer’s stage. Here are the 5-year survival rates for each stage:

• Localized (Stage I): 92.5%
• Regional (Stage II and III): 73.4%
• Distant (Stage IV): 29.4%

These numbers show why finding cancer early is so important. Early detection means a much better chance of survival compared to finding it later.

Survival Rate Trends Over Time

Looking at survival rate trends over time helps us see how well treatments are working. While survival rates have gotten better, there’s more work to be done.

Some important trends include:

1. Survival rates are going up for those diagnosed early.
2. Thanks to better surgery and chemotherapy, treatment results are improving.
3. New research on targeted and immunotherapies looks promising for the future.

By knowing these trends and current stats, we can tackle the challenges and seize the opportunities to boost ovarian cancer survival rates.

Global Perspective on Ovarian Cancer Survival

Ovarian cancer survival rates vary worldwide. This is due to differences in healthcare access and when cancer is diagnosed. It’s key to understand these differences to help improve survival rates globally.

Survival Rates in High-Income Countries

In high-income countries, ovarian cancer survival rates are generally higher. This is thanks to advanced healthcare systems and early detection. Countries with strong screening programs and cancer treatment centers have better ovarian cancer overall survival rates.

These countries have better access to treatment for ovarian cancer. This includes surgery, chemotherapy, and targeted therapies. This shows how important healthcare infrastructure is for better cancer outcomes.

Canadian 5-Year Net Survival

Canada has notable ovarian cancer survival statistics. The 5-year net survival rate for ovarian cancer in Canada is about 44%. This means about 44% of women with ovarian cancer survive for at least five years after diagnosis, adjusting for background mortality.

This rate shows Canada’s healthcare system is making progress in managing ovarian cancer. Yet, there’s a need for more improvement, mainly in early detection and treatment.

Factors Affecting Global Survival Disparities

Several factors cause global disparities in ovarian cancer survival rates. These include differences in healthcare access, economic status, and when cancer is diagnosed. In low-income countries, limited healthcare access and delayed diagnosis lead to lower survival rates.

Also, how cancer data is collected and registered varies worldwide. This makes it hard to compare survival rates accurately across countries.

To address these disparities, we need a multi-faceted approach. This includes improving healthcare infrastructure, better cancer data collection, and promoting early detection and treatment globally.

Factors Affecting Ovarian Cancer Prognosis

Many factors influence how well someone with ovarian cancer will do. Knowing these factors helps doctors create better treatment plans. This can lead to better results for patients.

Stage at Diagnosis

The stage of ovarian cancer when it’s found is very important. Finding it early greatly increases chances of survival. For example, those found at Stage I have a much better chance than those at Stage III or IV.

• Stage I: Cancer is only in the ovaries, with a higher survival rate.
• Stage III or IV: Cancer has spread beyond the pelvis, leading to lower survival rates.

Cancer Type and Grade

The type and grade of ovarian cancer also matter. High-grade tumors usually have a worse outlook than low-grade ones. Serous carcinomas, for instance, are common and aggressive.

Patient Age and Overall Health

A patient’s age and health also play a role. Younger people with fewer health problems usually do better. Older patients or those with other health issues may face more challenges.

Genetic Factors

Genetic factors, like BRCA1 and BRCA2 mutations, can also impact prognosis and treatment. Patients with these mutations might benefit from specific therapies.

Understanding these factors helps doctors tailor treatments. This can lead to better survival rates and outcomes for patients with ovarian cancer.

The Challenge of Late Detection

Ovarian cancer is often found too late, which makes treatment harder. This late detection is a big reason why survival rates are low.

Why Two-Thirds of Cases Are Found at Advanced Stages

Many things make it hard to catch ovarian cancer early. The symptoms in the early stages are often not clear. This makes it tough for both patients and doctors to spot the disease early.

Vague Symptoms: Symptoms like bloating, abdominal pain, and trouble eating are common in many other conditions. This leads to delays in getting a diagnosis.

Lack of Effective Screening: Unlike some other cancers, there’s no good screening test for ovarian cancer that works for everyone.

Vague Symptoms and Diagnostic Difficulties

The symptoms of ovarian cancer in its early stages are not clear. This makes it hard to diagnose. Patients might think their symptoms are from something less serious, leading to delays in getting help.

“The symptoms of ovarian cancer are often mistaken for other conditions, making early detection challenging.”

There’s no reliable screening test for ovarian cancer. Research is ongoing for biomarkers and screening methods. But for now, diagnosis usually happens after symptoms prompt a doctor’s visit.

Impact on Treatment Success

When ovarian cancer is found late, treatment is harder. The cancer has likely spread, making it tougher to treat.

Stage at Diagnosis	5-Year Survival Rate
Stage I	90%
Stage III	30-40%
Stage IV	15-20%

The survival rate difference between early and late diagnosis shows how important early detection is. We need better ways to diagnose and more awareness about ovarian cancer symptoms to improve treatment results.

Diagnosing Ovarian Cancer

Ovarian cancer diagnosis is a complex process. It starts with recognizing warning signs and using the right tests. Finding the right treatment depends on this journey.

Recognizing Warning Signs

The first step is to notice the warning signs of ovarian cancer. Common symptoms include:

• Pelvic or abdominal pain
• Bloating or swelling in the abdomen
• Difficulty eating or feeling full quickly
• Urinary urgency or frequency

These symptoms can be vague and mistaken for other issues. A gynecologic oncologist, says,

“The symptoms of ovarian cancer are often nonspecific, which can lead to delays in diagnosis.”

Diagnostic Tests and Procedures

When symptoms are noticed, several tests are used to confirm ovarian cancer. These include:

Diagnostic Test	Description
Pelvic Exam	A manual examination to check for abnormalities in the reproductive organs.
Imaging Tests (e.g., Ultrasound, CT Scan)	Used to visualize the ovaries and detect any tumors or abnormalities.
Blood Tests (e.g., CA-125)	Measures the level of CA-125 protein in the blood, which can be elevated in ovarian cancer.
Biopsy	A surgical procedure to remove a sample of tissue for pathological examination.

Imaging tests are key in diagnosing ovarian cancer. They help see how far the disease has spread.

Screening Limitations

Even with better tests, there are big challenges in screening for ovarian cancer. There’s no reliable test for everyone. The CA-125 blood test and ultrasound are used for high-risk groups, but their impact is debated.

Improving screening is vital. Early detection is key to better survival rates and treatment for ovarian cancer patients.

Staging of Ovarian Cancer

The stage of ovarian cancer is key to knowing survival chances and treatment plans. It’s based on how far the tumor has spread from the ovaries.

Stage I: Cancer Limited to Ovaries (91-95% Survival)

In Stage I, the cancer stays in one or both ovaries. Patients have a 91% to 95% chance of surviving 5 years. Finding it early greatly helps.

Stage II: Cancer in Pelvis (60-70% Survival)

Stage II means the cancer has spread to the pelvis but not further. Survival rates are 60% to 70% at this stage. Treatment often includes surgery and chemotherapy.

Stage III: Cancer in Abdomen (30-40% Survival)

Stage III shows the cancer has reached the abdominal cavity. Survival rates are 30% to 40% here. Treatment usually combines surgery and chemotherapy.

Stage IV: Distant Metastasis (15-20% Survival)

Stage IV means the cancer has spread to distant areas like the liver or lungs. Survival rates are just 15% to 20%. Treatment aims to manage symptoms and improve life quality.

Knowing the stage of ovarian cancer is vital. It helps both patients and doctors choose the right treatment and understand what to expect.

Stage	Description	5-Year Survival Rate
Stage I	Cancer limited to ovaries	91-95%
Stage II	Cancer in pelvis	60-70%
Stage III	Cancer in abdomen	30-40%
Stage IV	Distant metastasis	15-20%

Standard Treatment Approaches

Ovarian cancer treatment uses many methods to help patients. We’ll look at surgery, chemotherapy, and radiation therapy. We’ll also talk about how to plan treatment.

Surgical Interventions

Surgery is key in treating ovarian cancer. The main goal is to remove as much tumor as possible. Cytoreductive surgery helps make other treatments work better.

We use surgery to find out how far the cancer has spread. This helps us plan the next steps. For young patients, fertility-sparing surgery might be an option to keep fertility.

Chemotherapy Protocols

Chemotherapy is a big part of treating ovarian cancer, mainly for advanced stages. Platinum-based chemotherapy and taxane-based drugs are often used together. The right treatment depends on the cancer stage and the patient’s health.

• First-line treatment usually includes carboplatin and paclitaxel.
• Intraperitoneal chemotherapy is an option for advanced cancer.
• Maintenance chemotherapy helps prevent cancer from coming back.

Radiation Therapy

Radiation therapy is used less often but can help in some cases. It’s used for symptom relief or in some cases of cancer that comes back.

“Radiation therapy can provide significant relief for patients with advanced ovarian cancer, improving their quality of life.”

NCCN Guidelines for Ovarian Cancer

Treatment Planning Considerations

Planning treatment for ovarian cancer needs a detailed approach. We consider the cancer stage, patient health, and personal wishes. We work with patients to create a treatment plan that meets their needs.

By using a mix of treatments, we aim to give the best care for ovarian cancer patients.

Advanced and Emerging Treatments

Ovarian cancer treatment is getting better fast. New therapies are giving patients hope. We’re learning more about this disease, leading to better treatments and a better life for patients.

Targeted Therapies

Targeted therapies are a big step forward. They target specific molecules in cancer cells. For example, bevacizumab stops tumors from growing by blocking blood vessels.

Olaparib and niraparib are for those with certain genetic changes. They help patients with BRCA1 and BRCA2 mutations.

Studies show these therapies are improving survival and response rates. PARP inhibitors are key for treating ovarian cancer with BRCA mutations.

Immunotherapy Approaches

Immunotherapy uses the body’s immune system to fight cancer. It includes checkpoint inhibitors, vaccines, and T-cell therapy. Checkpoint inhibitors like pembrolizumab and nivolumab boost the immune system against cancer cells.

“Immunotherapy has the power to change ovarian cancer treatment. It offers new hope for those with few options.”

Oncologist

PARP Inhibitors and Maintenance Therapy

PARP inhibitors are key in maintenance therapy, mainly for BRCA mutation patients. They block the PARP enzyme, causing cancer cells to die. This therapy has greatly improved survival for advanced ovarian cancer patients.

PARP Inhibitor	Clinical Benefit	Patient Population
Olaparib	Improved PFS in BRCA mutated patients	Newly diagnosed advanced ovarian cancer
Niraparib	Prolonged PFS regardless of BRCA status	Recurrent ovarian cancer
Rucaparib	Effective in BRCA mutated and HRD positive patients	Recurrent ovarian cancer

Precision Medicine in Ovarian Cancer

Precision medicine is changing how we treat ovarian cancer. It tailors treatments to each patient based on their tumor’s genetics. This approach aims to improve outcomes and reduce side effects.

As we move forward, combining targeted therapies, immunotherapy, PARP inhibitors, and precision medicine is making care better. These new treatments bring hope to patients. They show the importance of ongoing research and trials in improving survival and quality of life.

Treatment Strategies by Stage

Ovarian cancer treatment changes with the disease’s stage. Each patient gets a treatment plan that fits their needs. The stage at diagnosis is key in choosing the right treatment.

Early-Stage Treatment Approaches

Early-stage ovarian cancer patients often start with surgery. The goal is to remove the tumor and affected tissues. Surgical interventions vary, depending on the disease’s extent and the patient’s health.

After surgery, some may get adjuvant chemotherapy. This is to lower the chance of the cancer coming back. The choice to use chemotherapy depends on the cancer type and grade.

Advanced-Stage Treatment Strategies

Advanced ovarian cancer needs a stronger treatment plan. This usually includes surgery and chemotherapy. The aim is to control the disease, ease symptoms, and improve life quality.

Neoadjuvant Chemotherapy

Some advanced ovarian cancer patients get neoadjuvant chemotherapy first. This shrinks the tumor before surgery. It can make surgery easier and may help patients live longer.

Palliative Care Considerations

When treatments can’t cure ovarian cancer, palliative care is vital. It helps manage symptoms, pain, and stress. The goal is to improve the patient’s life quality.

Understanding treatment by stage helps doctors create personalized plans. This approach improves outcomes and survival rates for each patient.

Managing Recurrence: The Major Challenge

Recurrence in ovarian cancer is a big challenge. It needs careful management. Despite new treatments, many patients face recurrence.

Recurrence Rates and Patterns

How often ovarian cancer comes back varies. It depends on when it was first found and how well it was treated. Most recurrences happen in the first two years after treatment.

Knowing when and where recurrence happens helps us plan better. We look at where it comes back, how long it takes, and the patient’s health.

Time to Recurrence	Recurrence Rate
Within 6 months	30%
6-12 months	20%
1-2 years	25%
After 2 years	25%

Treatment Options After Recurrence

When ovarian cancer comes back, treatment choices vary. They depend on where it comes back, past treatments, and the patient’s health. Treatments include chemotherapy, targeted therapy, and surgery.

Chemotherapy is key in treating ovarian cancer that comes back. The type of chemotherapy depends on how well it worked before and how long ago it was used.

“The management of recurrent ovarian cancer requires a multidisciplinary approach, incorporating the latest evidence-based treatments and a patient-centered care model.” – Gynecologic Oncologist

Platinum-Sensitive vs. Platinum-Resistant Recurrence

It’s important to know if the cancer is platinum-sensitive or platinum-resistant. Platinum-sensitive means the cancer responds to platinum-based chemotherapy and comes back six months or more after treatment.

Platinum-resistant recurrence happens when the cancer comes back within six months of platinum-based chemotherapy. Knowing this helps decide the best treatment and what to expect.

• Platinum-sensitive recurrence: Treatment options include re-treatment with platinum-based chemotherapy.
• Platinum-resistant recurrence: Treatment options may include non-platinum chemotherapy regimens, targeted therapy, or participation in clinical trials.

Understanding these differences is key to making a good treatment plan for ovarian cancer that comes back.

Liv Hospital’s Approach to Ovarian Cancer Treatment

Our team at Liv Hospital is committed to helping ovarian cancer patients live better lives. We know ovarian cancer is complex and needs a detailed treatment plan.

Mission and Vision in Cancer Care

At Liv Hospital, we aim to provide top-notch healthcare and support for our patients. We dream of a future where ovarian cancer is caught early and treated well, leading to better patient results. Our cancer care program is built to make this dream a reality by using proven treatments and caring for each patient personally.

Our dedication to ovarian cancer treatment shows in our modern facilities and skilled team. We keep up with the latest in medical research and technology to give our patients the best care.

Evidence-Based Treatment Protocols

We follow international standards for treating ovarian cancer, ensuring our patients get the best care. Our treatment plans are made just for each patient, considering the cancer’s stage, type, and the patient’s health.

Our approach includes:

• Surgical methods that aim to reduce recovery time
• Chemotherapy plans that are effective yet gentle on the body
• Targeted therapies that target cancer cells, protecting healthy tissues

We aim to care for our patients fully, not just their physical health but also their emotional and mental well-being.

Multidisciplinary Team Approach

Our ovarian cancer treatment program is based on a team effort. Our team includes gynecologic oncologists, medical oncologists, radiologists, pathologists, and support staff. They all work together to create a treatment plan that’s right for each patient.

Specialist	Role in Ovarian Cancer Treatment
Gynecologic Oncologist	Surgical expertise and overseeing the overall treatment plan
Medical Oncologist	Administering chemotherapy and other systemic treatments
Radiologist	Imaging and diagnostic support

Our team’s collaboration ensures each patient gets all-around, well-coordinated care. This approach improves outcomes and enhances quality of life.

Living with Ovarian Cancer

People with ovarian cancer face many challenges. These include physical, emotional, and social issues. The journey from diagnosis to treatment and beyond is tough, affecting not just the patient but also their family.

Physical and Emotional Challenges

Ovarian cancer and its treatment can cause a lot of pain, tiredness, and stomach problems. These physical issues often lead to emotional struggles like anxiety, depression, and fear of the cancer coming back. The emotional impact can be as big as the physical symptoms, affecting how well a person lives.

One patient shared their feelings, saying,

“It’s like living in a constant state of uncertainty, not knowing what tomorrow will bring.”

This shows the emotional battle many patients go through. It highlights the need for strong support.

Quality of Life Considerations

Keeping a good quality of life is key for those with ovarian cancer. This means managing symptoms, reducing side effects, and taking care of emotional and mental health. Good pain management and supportive care are key to quality care, helping patients stay independent and proud.

Improving quality of life involves several things:

• Nutritional support to handle side effects
• Psychological counseling for anxiety and depression
• Palliative care for better symptom management
• Support groups for emotional and social support

Support Systems and Resources

A strong support system is essential for those with ovarian cancer. This includes family, friends, healthcare teams, and support groups. Having access to resources like counseling, nutrition advice, and pain management can greatly improve well-being.

We believe in a team approach to care. This ensures patients get all the support they need. By tackling the physical, emotional, and social hurdles of ovarian cancer, we can boost survival rates and improve life quality for those affected.

Prevention and Risk Reduction Strategies

To lower the risk of ovarian cancer, it’s important to know its risk factors. Some risks can’t be changed, but others can be managed. This can be done through lifestyle changes and medical treatments.

Known Risk Factors

Several factors can increase the risk of ovarian cancer. These include:

• Family history of ovarian or breast cancer
• Genetic mutations, such as BRCA1 and BRCA2
• Age, with most cases occurring in women over 50
• Reproductive history, including never having children or having a first child after 35
• Hormone replacement therapy (HRT) after menopause

Knowing these risk factors is key. It helps assess personal risk and talk about preventive steps with doctors.

Preventive Measures

While not all ovarian cancer can be prevented, some steps may help lower the risk:

1. Using oral contraceptives, which have been shown to decrease ovarian cancer risk
2. Breastfeeding, as it may lower the risk
3. Tubal ligation or hysterectomy, which can reduce the risk in some cases
4. Maintaining a healthy weight, as obesity is linked to increased risk

Talking to a healthcare provider about these options is important. They can explain the benefits and risks.

Genetic Testing and Counseling

Women with a family history or genetic predisposition should consider genetic testing and counseling. Testing for BRCA1 and BRCA2 mutations can identify those at higher risk. Counseling helps understand how to manage this risk, including preventive surgeries or close monitoring.

A medical expert notes, “Genetic testing is key in preventing and early detecting ovarian cancer. It allows for personalized risk assessment and management.”

“Genetic counseling is not just about testing; it’s about understanding your risk and making informed decisions about your health.”

By knowing the risk factors and taking preventive steps, women can lower their chance of getting ovarian cancer. Here’s a summary of key risk factors and preventive measures:

Risk Factors	Preventive Measures
Family history	Oral contraceptives
Genetic mutations	Breastfeeding
Age over 50	Tubal ligation or hysterectomy
Reproductive history	Maintaining a healthy weight
Hormone replacement therapy	Genetic testing and counseling

Research and Future Directions in Ovarian Cancer Treatment

Ovarian cancer treatment is changing fast, with new research bringing hope for better survival rates. We’re learning more about this disease every day. New ways to fight it are being explored.

Promising Clinical Trials

Clinical trials are key in finding new ovarian cancer treatments. Right now, many promising trials are happening. They’re looking at:

• Targeted therapies that attack specific cancer cell mutations.
• Immunotherapies that use the immune system to fight cancer.
• Combination treatments that mix old and new therapies for better results.

These trials could bring new treatments and hope for better patient outcomes.

Biomarker Research

Biomarkers are vital for early detection and treatment of ovarian cancer. Scientists are working hard to find new biomarkers. They aim to:

1. Spot ovarian cancer early, when it’s easier to treat.
2. Know how patients will react to certain treatments, for better care.
3. Keep track of how the disease is doing, so we can act fast.

Good biomarkers could lead to earlier diagnosis and more focused treatments. This could greatly improve survival rates.

Early Detection Technologies

Early detection is essential for better survival rates. New tech is helping us find ovarian cancer sooner. This includes:

• Advanced imaging techniques that spot tumors more accurately.
• Liquid biopsies that find cancer DNA in the blood, helping catch cancer early.

These tools could help us find ovarian cancer when it’s easier to treat.

As research moves forward, we’re hopeful about ovarian cancer treatment’s future. New studies and tech could lead to better treatments and survival rates. We’re committed to leading in these advancements, giving our patients the best care.

Conclusion

Ovarian cancer survival rates have improved over time. Yet, it’s a tough disease because it’s often caught late. Knowing the survival rate is key for both patients and doctors to choose the best treatment. Early detection is key to better survival chances. If caught early, the outlook is much brighter. But, most cases are found when the cancer has spread, making treatment harder and survival rates lower. Using surgery, chemotherapy, and new treatments like targeted therapy and immunotherapy is important. Research into new treatments and ways to find cancer early is promising. It could lead to better survival rates in the future. We know ovarian cancer isn’t always curable. But, thanks to medical progress and a team approach to care, outcomes are getting better. By focusing on finding cancer early and treating it well, we aim to improve survival rates and quality of life for those affected.

FAQ

References

Ovarian cancer incidence in the U.S. is about 10.3 cases per 100,000 women annually; the death rate is about 5.9 per 100,000. The 5-year relative survival across all stages is ~51.6%. SEER

In more developed countries, the 5-year survival rate for ovarian cancer ranges from about 36% to 46%, though in lower-income countries it is much lower. World Ovarian Cancer Coalition

In Canada, the 5-year net survival for ovarian, fallopian tube, and primary peritoneal cancers is approximately 44%. Canadian Cancer Society

The lifetime risk of developing ovarian cancer is about 1 in 91; the lifetime risk of dying from it is about 1 in 143 in the U.S. American Cancer Society+1

Globally, in 2022 there were ~324,603 women diagnosed with ovarian cancer. By 2050, new cases are projected to increase by ~55% (to nearly half a million annually), with a nearly 70% increase in deaths.